# Pharmacokinetic and Pharmacodynamic Properties of BIOD-105 and BIOD-107 Compared to Humalog® in Subjects With Type 1 Diabetes

> **NCT01334151** · PHASE1 · COMPLETED · sponsor: **Biodel** · enrollment: 13 (actual)

## Conditions studied

- Diabetes Mellitus Type 1

## Interventions

- **DRUG:** Insulin LISPRO
- **DRUG:** recombinant human insulin

## Key facts

- **NCT ID:** NCT01334151
- **Lead sponsor:** Biodel
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2013-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01334151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01334151, "Pharmacokinetic and Pharmacodynamic Properties of BIOD-105 and BIOD-107 Compared to Humalog® in Subjects With Type 1 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01334151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*